Use of arsentic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) .1. Arsenic causes both apoptosis and partial differentiation of NB4 and fresh APL cells in vitro and in vivo

被引：0
|
作者：
Chen, Z
Chen, GO
Shi, XG
Tang, W
Zhu, J
Xiong, SM
Ni, IH
Gazin, C
Waxman, S
Wang, ZY
Chen, SJ
机构：
[1] SHANGHAI MED UNIV 2,RUI JIN HOSP,SHANGHAI INST HEMATOL,SHANGHAI,PEOPLES R CHINA
[2] HOP ST LOUIS,PARIS,FRANCE
[3] MT SINAI MED CTR,NEW YORK,NY 10029
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：864 / 864
页数：1
相关论文
共 42 条
  • [31] Selective inhibition of MEK1 phosphorylation overcomes arsenic trioxide (ATO) resistance in NB4 cells and enhances apoptosis of primary acute promyelocytic leukemia blasts.
    Lunghi, P
    Tabilio, A
    Lo Coco, F
    Pelicci, PG
    Bonati, A
    BLOOD, 2003, 102 (11) : 20A - 20A
  • [32] Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide
    Lu Zuo
    Jian Li
    Yang Yang
    Xuan Wang
    Ti Shen
    Cai-min Xu
    Zhi-nan Zhang
    Annals of Hematology, 2004, 83 : 751 - 758
  • [33] Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide
    Zuo, L
    Li, JA
    Yang, Y
    Wang, X
    Shen, T
    Xu, CM
    Zhang, ZN
    ANNALS OF HEMATOLOGY, 2004, 83 (12) : 751 - 758
  • [34] Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice
    K Kinjo
    M Kizaki
    A Muto
    Y Fukuchi
    A Umezawa
    K Yamato
    T Nishihara
    J Hata
    M Ito
    Y Ueyama
    Y Ikeda
    Leukemia, 2000, 14 : 431 - 438
  • [35] Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice
    Kinjo, K
    Kizaki, M
    Muto, A
    Fukuchi, Y
    Umezawa, A
    Yamato, K
    Nishihara, T
    Hata, J
    Ito, M
    Ueyama, Y
    Ikeda, Y
    LEUKEMIA, 2000, 14 (03) : 431 - 438
  • [36] Long-term follow-up confirms the benefit of all-trams retinoic acid (ATRA) and arsenic trioxide (As2O3) as front line therapy for newly diagnosed acute promyelocytic leukemia (APL).
    Liu, Yuan-Fang
    Zhu, Yong-Mei
    Shi, Zhan-Zhong
    Li, Jun-Min
    Wang, Li
    Chen, Yu
    Shen, Zhi-Xiang
    Hu, Jiong
    BLOOD, 2006, 108 (11) : 170A - 170A
  • [37] Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710
    Powell, B. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family
    Di Noto, R
    Boccuni, P
    Costantini, S
    Dello Russo, A
    Lo Pardo, C
    Copia, C
    Annunziata, M
    Cimino, R
    Ferrara, F
    Del Vecchio, L
    TISSUE ANTIGENS, 1999, 54 (06): : 597 - 602
  • [39] P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelocytic leukemia cells
    A Takeshita
    K Shinjo
    K Naito
    H Matsui
    K Shigeno
    S Nakamura
    T Horii
    M Maekawa
    K Kitamura
    T Naoe
    K Ohnishi
    R Ohno
    Leukemia, 2003, 17 : 648 - 650
  • [40] P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (AS2O3), but are not the main mechanism of AS2O3-resistance in acute promyelocytic leukemia cells
    Takeshita, A
    Shinjo, K
    Naito, K
    Matsui, H
    Shigeno, K
    Nakamura, S
    Horii, T
    Maekawa, M
    Kitamura, K
    Naoe, T
    Ohnishi, K
    Ohno, R
    LEUKEMIA, 2003, 17 (03) : 648 - 650
12345